Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: NASDAQ CM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Idera Pharmaceuticals Inc

+ Add to Watchlist

IDRA:US

4.8700 USD 0.2700 5.25%

As of 20:10:00 ET on 02/27/2015.

Snapshot for Idera Pharmaceuticals Inc (IDRA)

Open: 5.1500 Day's Range: 4.8700 - 5.1794 Volume: 4,556,764
Previous Close: 5.1400 52wk Range: 1.9350 - 6.8740 1-Yr Rtn: -15.89%

Stock Chart for IDRA

No chart data available.
  • IDRA:US 4.8800
  • 1D
  • 1M
  • 1Y
5.1400
Interactive IDRA Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for IDRA

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -0.4300
Est. EPS (USD) (12/2014) -0.4450
Est. PEG Ratio -
Market Cap (M USD) 559.22
Shares Outstanding (M) 114.83
30 Day Average Volume 2,052,943
Price/Book (mrq) 8.8355
Price/Sale (ttm) 5,321.6603
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 03/13/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for IDRA

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for IDRA

Idera Pharmaceuticals, Inc. is a biotechnology company. The Company develops therapeutics that modulate the immune response through Toll-like receptors. Idera is working on therapeutics for oncology, asthma/allergy, and infectious diseases.

Vincent J Milano "Vin"President/CEOSudhir D Agrawal "Phil"President:Research
Louis J Arcudi IIISenior VP/CFO/Treasurer/SecyLouis BrennerSenior VP/Chief Medical Ofcr
More Company Profile & Key Executives for IDRA

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil